1. S106: UBTF-ATXN7L3 GENE FUSION DUE TO 17Q21.31 DELETION DEFINES NOVEL HIGH-RISK ALL SUBTYPE AMENABLE TO MRD-BASED TREATMENT INTENSIFICATION. (23rd June 2022) Authors: Bastian, L.; Hartmann, A.; Beder, T.; Hänzelmann, S.; Kässens, J.; Bultmann, M.; Höppner, M. P.; Franzenburg, S.; Wittig, M.; Franke, A.; Nagel, I.; Spielmann, M.; Reimer, N.; Busch, H.; Schwartz, S.; Steffen, B.; Viardot, A.; Döhner, K.; Kondakci, M.; Wulf, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗